Literature DB >> 7286048

High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen.

E Wåhlin-Boll, B Brantmark, A Hanson, A Melander, C Nilsson.   

Abstract

A high-pressure liquid chromatographic technique was developed which allowed concurrent measurement of acetylsalicylic acid (ASA) and salicylic acid (SA) in plasma. ASA was extensively deacetylated to SA not only in vivo but also in vitro, even in frozen plasma. The in vitro conversion could be prevented by physostigmine. In vivo, ASA was eliminated within few hours, whereas SA was continuously present following daily administration of conventional doses of ASA. A slight modification of a similar method, originally developed for naproxen determination [9], was found appropriate for measurement of the SA derivative diflunisal, of two non-SA antiinflammatory agents, indomethacin and indoprofen, and of a related anti-platelet agent, indobufen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286048     DOI: 10.1007/BF00615408

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

Review 1.  Pharmacokinetics of salicylate in man.

Authors:  G Levy
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

2.  Diflunisal: six-month experience in osteoarthritis.

Authors:  A Andrew; B Rodda; L Verhaest; C Van Winzum
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

3.  Evidence for a sex-linked difference in aspirin metabolism.

Authors:  R Menguy; L Desbaillets; Y F Masters; S Okabe
Journal:  Nature       Date:  1972-09-08       Impact factor: 49.962

4.  Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate.

Authors:  D A Brodie; K F Hooke
Journal:  Am J Dig Dis       Date:  1971-11

5.  Salicylates and bleeding: the aspirin tolerance test.

Authors:  A J Quick
Journal:  Am J Med Sci       Date:  1966-09       Impact factor: 2.378

6.  Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma.

Authors:  G W Peng; M A Gadalla; V Smith; A Peng; W L Chiou
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

7.  Determination of acetylsalicylic acid and salicylic acid in plasma.

Authors:  M Rowland; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

8.  Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

9.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

10.  Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis.

Authors:  L Lindholm; C Ekdahl; E Håkansson; A Melander; S Olsson; B Svensson; E Wählin-Boll
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

  10 in total
  16 in total

1.  Cerebral blood flow and indomethacin drug levels in subjects with and without central nervous side effects.

Authors:  P Seideman; M von Arbin
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  Pharmacokinetics of intraarticular indomethacin in patients with osteoarthritis.

Authors:  G Neander; L O Eriksson; E Wållin-Boll; H Ersmark; A Grahnen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Diflunisal and its conjugates in patients with renal failure.

Authors:  R G Dickinson; R K Verbeeck; A R King; A C Restifo; S M Pond
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

5.  Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig.

Authors:  J Maksem; N Jacobson; D H Neiderhiser
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

6.  Reduction of paracetamol and aspirin metabolism during viral hepatitis.

Authors:  C Jorup-Rönström; B Beermann; E Wåhlin-Boll; A Melander; S Britton
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

7.  Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.

Authors:  L O Erikson; E Wåhlin-Boll; I Odar-Cederlöf; L Lindholm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.

Authors:  E Elvander-Ståhl; A Melander; E Wåhlin-Boll
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

9.  Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.

Authors:  B Brantmark; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Pharmacokinetic interaction in beagle dogs of antiplatelet drugs: acetylsalicylic acid, dipyridamole and calcium dobesilate.

Authors:  C T Plessas; S Souras; P E Karayannacos; S T Plessas; I Dontas; D Kotsarelis; G Asimakopoulos; J Gogas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.